ZYMERGEN INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT July 29, 2020Investors’ Rights Agreement • March 23rd, 2021 • Zymergen Inc. • Services-commercial physical & biological research • Delaware
Contract Type FiledMarch 23rd, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 29th day of July, 2020, by and among Zymergen Inc., a Delaware corporation (the “Company”), the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors”, and the holders of Common Stock (as defined below) listed on Schedule B hereto, each of which is herein referred to as a “Common Holder” and collectively as the “Common Holders”.
ZYMERGEN INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT July 29, 2020Investors’ Rights Agreement • March 9th, 2021 • Zymergen Inc. • Services-commercial physical & biological research • Delaware
Contract Type FiledMarch 9th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 29th day of July, 2020, by and among Zymergen Inc., a Delaware corporation (the “Company”), the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors”, and the holders of Common Stock (as defined below) listed on Schedule B hereto, each of which is herein referred to as a “Common Holder” and collectively as the “Common Holders”.